Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
Cost of Revenue
Maccura Biotechnology Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
Cost of Revenue
-¥1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Cost of Revenue
-¥23.6B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cost of Revenue
-¥7.6B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cost of Revenue
-¥10.2B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cost of Revenue
-¥4.5B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-36%
|
|
Genscript Biotech Corp
HKEX:1548
|
Cost of Revenue
-$430m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
See Also
What is Maccura Biotechnology Co Ltd's Cost of Revenue?
Cost of Revenue
-1.3B
CNY
Based on the financial report for Mar 31, 2024, Maccura Biotechnology Co Ltd's Cost of Revenue amounts to -1.3B CNY.
What is Maccura Biotechnology Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
2%
Over the last year, the Cost of Revenue growth was 18%. The average annual Cost of Revenue growth rates for Maccura Biotechnology Co Ltd have been 13% over the past three years , 2% over the past five years .